Karen J. Quadrini
Prothena (United States)1 paperORCID 0009-0001-3113-5800OpenAlex
Papers
medRxivHumansPreprint
Tool converts plasma pTau217 values across testing platforms
Assays predicted amyloid-beta positivity with AUCs of 0.929 to 0.952, while simulated pTau217 screening cut amyloid PET scans by over 60%.Assays predicted amyloid-beta positivity with AUCs of 0.929 to 0.952, while simulated pTau217 screening cut amyloid PET scans by over 60%.